Neurology Market Research Reports & Industry Analysis

The notion “neurology” refers to a branch of medical scientific study dealing with central, peripheral and autonomic nervous systems, and their structure, functions and disorders, in particular. Companies involved in the neurology market produce a wide range of neurology devices. Neurology devices represent the largest and the most promising segments of the medical devices market.

In late 2016, the worldwide neurology devices market is expected to be over USD 7 billion. The largest neurology devices market is the USA, followed by Japan. Boston Scientific Corporation, DePuy Inc., CareFusion Corporation, Accuracy Inc. are amid major industry participants.

Research reports available in the Catalogue include data on the neurology devices market. The reports provide the profiles of the key vendors in the market space; analyses of trends factors affecting the market and forces contributing to the industry growth. The research studies evaluate the competitive landscape and future industry projections.

Found 116 publications
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis US$ 9,995.00

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The ... . Additional unmet needs still exists in terms of safety and efficacy. Will the drugs under development fulfil the unmet needs of the ...

Jan, 2013 271 pages
Japanese Market for Neurovascular Devices US$ 6,995.00

... at nearly $553 million. The Japanese market for neurological devices includes bare platinum coils, coated coils, liquid embolics, neurovascular stents, ... in this market will be driven by the rapidly growing aging population in Japan and the increased demand and acceptance of endovascular cerebral aneurysm ...

Nov, 2013 76 pages
Chinese Market for Neurological Devices US$ 6,995.00

... was valued at over $528 million. The Chinese market for neurological devices includes fixed pressure CSF shunts, adjustable pressure CSF ... -based stereotactic systems, frameless stereotactic systems and aneurysm clips. Market growth will be driven by the continued acceptance of aneurysm treatment procedures, ...

Nov, 2013 242 pages
EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022 US$ 3,995.00

... other than that of vascular origin.” This definition excludes cases of transient ischemic attacks (TIAs), which are neurological deficits lasting less than ... entire healthcare system in each country. Scope The Acute Ischemic Stroke (AIS) EpiCast Report provides an overview of the risk factors, comorbidities ...

Sep, 2013 86 pages
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it? US$ 645.00

With Sanofi securing European approval for its multiple sclerosis therapy Lemtrada last week, neurologists in the region have at their disposal a new option ... to limit the chance of patients using the drug developing PML. This week's Physician Views poll will ask neurologists based in the 5EU (France, Germany, ...

Sep, 2013
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU US$ 645.00

... (known collectively as the ABCRs), which for many years were positioned as the gold standard therapies of choice - see Physician Views Poll Results – ... do their best to rectify. Analysts at Barclays recently noted that 'importantly, the multiple sclerosis market has become more dynamic since the launch of ...

Sep, 2013
The Top 50 Neurodevice Companies Worldwide US$ 464.00

... , Number of Employees, Turnover and Foreign Trade. Report Target Market: 1) Neurodevice Companies Usage: competitive/financial analysis and strategic partner/alliance ... your business. Learn more about your target markets and target companies Top level research on all the major players in a market See ...

May, 2012 97 pages
The Top 30 Neurology Contract Research Organisations In Western Europe US$ 506.00

... 's Disease and Multiple Sclerosis. They are located right across Europe, from Belgium and the Netherlands to Sweden and Denmark. Profile ... , Biotechnology and Medical Device Associations The Top 30 Neurology Contract Research Organisations In Western Europe is a useful reference tool for CRO, pharmaceutical, ...

Aug, 2013 91 pages
Global Neurovascular Market: Trends & Opportunities (2013-18) US$ 800.00

... (Ev3) and Johnson & Johnson (Micrus). The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)” provides a detailed insight into the ... sphere. The report primarily focuses on the two chief segments of neurovascular disorder: hemorrhagic stroke and ischemic stroke. The report further ...

Jul, 2013 46 pages
Indian Neurological Devices Market US$ 5,995.00

In 2012, the Indian market for neurological devices was valued at $13.5 million. The Indian market for neurological devices includes detachable coils, liquid embolics, neurovascular stents, neurovascular catheters, neurovascular guidewires, neuromodulation systems, neuroendoscopes, stereotactic systems and ...

Aug, 2013 236 pages
Neurostimulation Devices Market, 2012-2017 US$ 1,699.00

... continue to be the largest segment in the neurostimulation devices market over the forecast period (2012 to 2017). 3. Deep Brain Stimulation (DBS) segment ... companies. It also contains a SWOT analysis and detailed profile of leading devices within this segment. We have looked at both the existing commercial ...

Nov, 2012 124 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H1 2014 US$ 2,000.00

... (Cushing's Disease) - Pipeline Review, H1 2014’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing's Disease), complete with ...

Apr, 2014 72 pages
Neuropathy – Pipeline Review, H1 2013 US$ 2,000.00

... key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...

Apr, 2013 77 pages
Essential Tremor – Pipeline Review, H1 2013 US$ 2,000.00

... reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...

Apr, 2013 32 pages
Global Deep Brain Stimulator Market 2012-2016 US$ 2,000.00

... the Americas, and the EMEA and APAC regions; it covers the Global Deep Brain Stimulator market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Boston Scientific Corp., ...

Apr, 2013 37 pages
Global Neurostimulation Devices Market 2012-2016 US$ 2,500.00

... could pose a challenge to the growth of this market. TechNavio's report, Global Neurostimulation Devices Market 2012-2016, has been prepared based on an in-depth ... . The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Medtronic Inc., ...

Apr, 2013 37 pages
Intraoperative Neuromonitoring Market in the US 2012-2016 US$ 2,000.00

... of 7.98 percent over the period 2012-2016. One of the key factors contributing to this market growth is the huge patient population with various neurological disorders. The Intraoperative Neuromonitoring market in the US has also been witnessing the trend of increasing mergers and acquisitions. ...

Feb, 2013 38 pages
European Neurological Device Markets US$ 8,995.00

In 2011, the total European market for neurological devices was valued at €628.3 million. Market growth will be driven by the continued acceptance of ... hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that ...

Mar, 2013 410 pages
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022'. ... have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant ...

Feb, 2013 136 pages
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022'. ... have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant ...

Feb, 2013 135 pages
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Spain Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 129 pages
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Japan Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 135 pages
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Italy Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 132 pages
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 ... , a growing middle class with better healthcare access, and increased epilepsy treatment in the whole population. However, loose government regulation of patent ...

Feb, 2013 128 pages
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 ... is the launch of generics and the high rate of generic substitution in Germany. In addition, strict government pricing restrictions will limit the the ...

Feb, 2013 136 pages
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 ... impact of key events as well the drivers and restraints affecting France Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...

Feb, 2013 130 pages
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022 US$ 4,995.00

... Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022'. ... general population, which drives the growth of the prevalent population of epilepsy patients, the AED market is fairly large, despite the relatively ...

Feb, 2013 114 pages
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022 US$ 3,995.00

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022 SUMMARY Alzheimer’s disease is the most common cause of dementia in people age 60 years and ... for care of persons affected with the disease. SCOPE The Alzheimer’s disease EpiCast Report provides an overview of the risk factors and ...

Feb, 2013 42 pages
Micromed S.p.A Market Share Analysis US$ 1,000.00

... ’s new report, “Micromed S.p.A Market Share Analysis” provides in-depth information on Micromed S.p.A’s market position in the neurological diagnostic equipments market. The report ... (in Revenues) information for the neurological diagnostic equipments market. All the key data-points are for 2011 and cover all ...

Jan, 2013 22 pages
Global Neurovascular Intervention Devices Market 2011-2015 US$ 1,500.00

... huge patient population with various neurological disorders. The Global Neurovascular Intervention Devices market has also been witnessing the trend of an increase ... in the report are Gore Medical, ITGI Medical Ltd., Neuro Interventional Therapeutics Inc., and Medtronic Inc. Key questions answered in this ...

Nov, 2012 44 pages
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] – Global Trends &... US$ 4,650.00

... market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP ... the neurointerventional device market for devices used in neurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coiling procedure and support ...

Oct, 2012 234 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2013 US$ 2,000.00

... , and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pituitary ACTH Hypersecretion (Cushing's Disease). Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, Half Year is built using data and information sourced ...

Oct, 2013 64 pages
Neuropathy - Pipeline Review, H2 2013 US$ 2,000.00

... and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built ... news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for ...

Oct, 2013 36 pages
Essential Tremor – Pipeline Review, H2 2012 US$ 2,000.00

... reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. REASONS ...

Oct, 2012 37 pages
Taiwan Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... GlobalData’s new report, “Taiwan Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides ... for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years ...

May, 2012 131 pages
South and Central America Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 3,500.00

... Devices and Others” provides key market data on the South and Central America Neurology Devices market – Argentina, Brazil and Mexico. The ... competition strategies by identifying who-stands-where in the South and Central America Neurology Devices competitive landscape. Develop capital investment strategies ...

May, 2012 107 pages
Saudi Arabia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... Devices and Others” provides key market data on the Saudi Arabia Neurology Devices market. The report provides value (USD million), volume ... Devices competitive landscape. Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What ...

May, 2012 137 pages
New Zealand Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... Devices and Others” provides key market data on the New Zealand Neurology Devices market. The report provides value (USD million), volume ( ... Devices competitive landscape. Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What ...

May, 2012 130 pages
Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 3,500.00

... -level profiles of key companies operating within the Middle East and Africa Neurology Devices market.. Key players covered include Medtronic, ... competition strategies by identifying who-stands-where in the Middle East and Africa Neurology Devices competitive landscape. Develop capital investment strategies ...

May, 2012 101 pages
Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 3,500.00

... GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides ... Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the ...

May, 2012 159 pages
Denmark Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... GlobalData’s new report, “Denmark Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides ... Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and ...

May, 2012 128 pages
United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... Devices and Others” provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume ... Devices competitive landscape. Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What ...

May, 2012 197 pages
United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... Devices and Others” provides key market data on the United Kingdom Neurology Devices market. The report provides value (USD million), volume ... Devices competitive landscape. Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What ...

May, 2012 143 pages
Sweden Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... GlobalData’s new report, “Sweden Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides ... for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years ...

May, 2012 136 pages
Spain Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... GlobalData’s new report, “Spain Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides ... for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years ...

May, 2012 131 pages
South Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... -level profiles of key companies operating within the South Africa Neurology Devices market. Key players covered include Medtronic, Inc., DePuy, ... competitive landscape. Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What ...

May, 2012 123 pages
Russian Federation Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles ... -level profiles of key companies operating within the Russian Federation Neurology Devices market. Key players covered include Medtronic, Inc., Stryker ...

May, 2012 135 pages
Republic of Korea Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and ... . Design competition strategies by identifying who-stands-where in the Republic of Korea Neurology Devices competitive landscape. Develop capital investment strategies by identifying ...

May, 2012 141 pages
Netherlands Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... Diagnostic Equipment, Neurostimulation Devices and Others Summary GlobalData’s new report, “Netherlands Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Netherlands Neurology ...

May, 2012 134 pages
Mexico Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others US$ 2,500.00

... GlobalData’s new report, “Mexico Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides ... for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years ...

May, 2012 134 pages
1 2 3 >
Skip to top